{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:56:27Z","timestamp":1793217387959,"version":"4.5.0"},"reference-count":137,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["gimjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Genetics in Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.gim.2025.101450","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:25:39Z","timestamp":1745925939000},"page":"101450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Smith-Lemli-Opitz syndrome: Clinical, biochemical, and genetic insights with emerging treatment opportunities"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7011-841X","authenticated-orcid":false,"given":"Amy","family":"Kritzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rana","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziano","family":"Pramparo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolan","family":"Terner-Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Vig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4177-4590","authenticated-orcid":false,"given":"Robert D.","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJM199401133300205","article-title":"Defective cholesterol biosynthesis associated with the Smith-Lemli-Opitz syndrome","volume":"330","author":"Tint","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gim.2025.101450_bib2","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0022-3476(64)80264-X","article-title":"A newly recognized syndrome of multiple congenital anomalies","volume":"64","author":"Smith","year":"1964","journal-title":"J Pediatr"},{"key":"10.1016\/j.gim.2025.101450_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ajmg.c.31341","article-title":"The RSH\/\u2018\u2018Smith\u2013Lemli\u2013Opitz\u2019\u2019 Syndrome: historical footnote","volume":"160","author":"Opitz","year":"2012","journal-title":"Am J Med Genet Part C (Sem Med Genet)"},{"issue":"14","key":"10.1016\/j.gim.2025.101450_bib4","doi-asserted-by":"crossref","first-page":"8181","DOI":"10.1073\/pnas.95.14.8181","article-title":"Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome","volume":"95","author":"Fitzky","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1086\/301936","article-title":"Mutations in the human sterol delta7-reductase gene at 11q12-13 cause Smith-Lemli-Opitz syndrome","volume":"63","author":"Wassif","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib6","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1086\/301982","article-title":"Smith-Lemli-Opitz syndrome is caused by mutations in the 7-dehydrocholesterol reductase gene","volume":"63","author":"Waterham","year":"1998","journal-title":"Am J Hum Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib7","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1006\/mgme.2000.3103","article-title":"Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome","volume":"72","author":"Battaile","year":"2001","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/1096-8628(20010722)102:1<18::AID-AJMG1376>3.0.CO;2-E","article-title":"Incidence of Smith-Lemli-Opitz syndrome in Ontario, Canada","volume":"102","author":"Nowaczyk","year":"2001","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/ajmg.1441","article-title":"Frequency and ethnic distribution of the common DHCR7 mutation in Smith-Lemli-Opitz syndrome","volume":"102","author":"Nowaczyk","year":"2001","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib10","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/00008480-199908000-00015","article-title":"RSH (so-called Smith-Lemli-Opitz) syndrome","volume":"11","author":"Opitz","year":"1999","journal-title":"Curr Opin Pediatr"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/pd.5018","article-title":"Smith-Lemli-Opitz syndrome carrier frequency and estimates of in utero mortality rates","volume":"37","author":"Lazarin","year":"2017","journal-title":"Prenat Diagn"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ajmg.1320050205","article-title":"Borderline normal intelligence in the Smith-Lemli-Opitz (RSH) syndrome","volume":"5","author":"Lowry","year":"1980","journal-title":"Am J Med Genet"},{"issue":"8857","key":"10.1016\/j.gim.2025.101450_bib15","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/0140-6736(93)90983-N","article-title":"Defective cholesterol biosynthesis in Smith-Lemli-Opitz syndrome","volume":"341","author":"Irons","year":"1993","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/ajmg.1320500409","article-title":"Abnormal cholesterol metabolism in the Smith-Lemli-Opitz syndrome: report of clinical and biochemical findings in four patients and treatment in one patient","volume":"50","author":"Irons","year":"1994","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib17","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1073\/pnas.95.4.1899","article-title":"Molecular cloning and expression of the human delta7-sterol reductase","volume":"95","author":"Moebius","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib18","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1172\/JCI200112103","article-title":"7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz\/RSH syndrome","volume":"108","author":"Fitzky","year":"2001","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib19","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/hmg\/10.6.555","article-title":"Biochemical, phenotypic and neurophysiological characterization of a genetic mouse model of RSH\/Smith--Lemli--Opitz syndrome","volume":"10","author":"Wassif","year":"2001","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1172\/JCI117678","article-title":"Reproducing abnormal cholesterol biosynthesis as seen in the Smith-Lemli-Opitz syndrome by inhibiting the conversion of 7-dehydrocholesterol to cholesterol in rats","volume":"95","author":"Xu","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.gim.2025.101450_bib21","series-title":"GeneReviews\u00ae","article-title":"Smith-Lemli-Opitz syndrome","author":"Nowaczyk","year":"1993"},{"key":"10.1016\/j.gim.2025.101450_bib24","series-title":"Encyclopedia of the Neurological Sciences","first-page":"221","article-title":"Smith-Lemli-Opitz syndrome","author":"Svoboda","year":"2014"},{"issue":"11","key":"10.1016\/j.gim.2025.101450_bib25","doi-asserted-by":"crossref","first-page":"2707","DOI":"10.1002\/ajmg.a.35376","article-title":"Growth charts for individuals with Smith-Lemli-Opitz syndrome","volume":"158A","author":"Lee","year":"2012","journal-title":"Am J Med Genet A"},{"issue":"1-2","key":"10.1016\/j.gim.2025.101450_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1006\/mgme.2000.3020","article-title":"Smith-Lemli-Opitz syndrome: the first malformation syndrome associated with defective cholesterol synthesis","volume":"71","author":"Battaile","year":"2000","journal-title":"Mol Genet Metab"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/jmg.37.5.321","article-title":"The Smith-Lemli-Opitz syndrome","volume":"37","author":"Kelley","year":"2000","journal-title":"J Med Genet"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ejhg.2008.10","article-title":"Smith-Lemli-Opitz syndrome: pathogenesis, diagnosis and management","volume":"16","author":"Porter","year":"2008","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<263::AID-AJMG4>3.0.CO;2-N","article-title":"Clinical and biochemical spectrum of patients with RSH\/Smith-Lemli-Opitz syndrome and abnormal cholesterol metabolism","volume":"68","author":"Cunniff","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gim.2025.101450_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-3101(23)00093-2","article-title":"Inborn errors of cholesterol biosynthesis","volume":"47","author":"Kelley","year":"2000","journal-title":"Adv Pediatr"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<270::AID-AJMG5>3.0.CO;2-Q","article-title":"Cardiovascular malformations in Smith-Lemli-Opitz syndrome","volume":"68","author":"Lin","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gim.2025.101450_bib32","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1017\/S146239941100189X","article-title":"Smith-Lemli-Opitz syndrome","volume":"13","author":"DeBarber","year":"2011","journal-title":"Expert Rev Mol Med"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib33","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/ajmg.c.31343","article-title":"Smith-Lemli-Opitz syndrome: phenotype, natural history, and epidemiology","volume":"160C","author":"Nowaczyk","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib34","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jpeds.2014.06.010","article-title":"Feeding impairments associated with plasma sterols in Smith-Lemli-Opitz syndrome","volume":"165","author":"Merkens","year":"2014","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib35","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1046\/j.1365-2133.1998.02231.x","article-title":"Photosensitivity associated with the Smith-Lemli-Opitz syndrome","volume":"138","author":"Charman","year":"1998","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<382::AID-AJMG5>3.0.CO;2-9","article-title":"Adrenal insufficiency in Smith-Lemli-Opitz syndrome","volume":"82","author":"Andersson","year":"1999","journal-title":"Am J Med Genet"},{"issue":"11","key":"10.1016\/j.gim.2025.101450_bib37","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1002\/ajmg.a.34271","article-title":"Adrenal function in Smith-Lemli-Opitz syndrome","volume":"155A","author":"Bianconi","year":"2011","journal-title":"Am J Med Genet A"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib38","first-page":"254","article-title":"Adrenal insufficiency and abnormal genitalia in a 46XX female with Smith-Lemli-Opitz syndrome","volume":"59","author":"Chemaitilly","year":"2003","journal-title":"Horm Res"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib39","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1515\/jpem-2017-0501","article-title":"Smith-Lemli-Opitz syndrome: clinical and biochemical correlates","volume":"31","author":"Donoghue","year":"2018","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"7","key":"10.1016\/j.gim.2025.101450_bib40","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1136\/jmg.27.7.465","article-title":"Smith-Lemli-Opitz syndrome. II: A disorder of the fetal adrenals?","volume":"27","author":"McKeever","year":"1990","journal-title":"J Med Genet"},{"issue":"8","key":"10.1016\/j.gim.2025.101450_bib41","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/ajmg.a.38125","article-title":"Normal IQ is possible in Smith-Lemli-Opitz syndrome","volume":"173","author":"Eroglu","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"Pt3","key":"10.1016\/j.gim.2025.101450_bib42","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1469-1809.2003.00034.x","article-title":"Smith-Lemli-Opitz syndrome and the DHCR7 gene","volume":"67","author":"Jira","year":"2003","journal-title":"Ann Hum Genet"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/1096-8628(20010115)98:2<191::AID-AJMG1030>3.0.CO;2-M","article-title":"Behavior phenotype in the RSH\/Smith-Lemli-Opitz syndrome","volume":"98","author":"Tierney","year":"2001","journal-title":"Am J Med Genet"},{"issue":"14","key":"10.1016\/j.gim.2025.101450_bib44","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/ajmg.a.31294","article-title":"The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome","volume":"140","author":"Sikora","year":"2006","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib45","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1172\/JCI118223","article-title":"Markedly inhibited 7-dehydrocholesterol-delta 7-reductase activity in liver microsomes from Smith-Lemli-Opitz homozygotes","volume":"96","author":"Shefer","year":"1995","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.gim.2025.101450_bib46","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1021\/ja9080265","article-title":"Oxysterols from free radical chain oxidation of 7-dehydrocholesterol: product and mechanistic studies","volume":"132","author":"Xu","year":"2010","journal-title":"J Am Chem Soc"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib47","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S0022-2275(20)31660-6","article-title":"Oxysterols in the circulation of patients with the Smith-Lemli-Opitz syndrome: abnormal levels of 24S- and 27-hydroxycholesterol","volume":"42","author":"Bj\u00f6rkhem","year":"2001","journal-title":"J Lipid Res"},{"issue":"10","key":"10.1016\/j.gim.2025.101450_bib48","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1002\/ajmg.a.38361","article-title":"Vitamin D levels in Smith-Lemli-Opitz syndrome","volume":"173","author":"Movassaghi","year":"2017","journal-title":"Am J Med Genet A"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s10545-005-3676-8","article-title":"Vitamin D status in patients affected by Smith-Lemli-Opitz syndrome","volume":"28","author":"Rossi","year":"2005","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib50","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/ajmg.1320280320","article-title":"Female external genitalia and m\u00fcllerian duct derivatives in a 46,XY infant with the Smith-Lemli-Opitz syndrome","volume":"28","author":"Bialer","year":"1987","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib51","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ajmg.10211","article-title":"Smith-Lemli-Opitz syndrome: new mutation with a mild phenotype","volume":"108","author":"Prasad","year":"2002","journal-title":"Am J Med Genet"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6920","article-title":"Keeping you on your toes: Smith-Lemli-Opitz syndrome is an easily missed cause of developmental delays","volume":"11","author":"Coupe","year":"2023","journal-title":"Clin Case Rep"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib53","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmg.2007.11.004","article-title":"Mild Smith-Lemli-Opitz syndrome: further delineation of 5 Polish cases and review of the literature","volume":"51","author":"Jezela-Stanek","year":"2008","journal-title":"Eur J Med Genet"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib54","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/(SICI)1096-8628(19980806)78:5<419::AID-AJMG5>3.0.CO;2-G","article-title":"Smith-Lemli-Opitz syndrome: phenotypic extreme with minimal clinical findings","volume":"78","author":"Nowaczyk","year":"1998","journal-title":"Am J Med Genet"},{"issue":"6-7","key":"10.1016\/j.gim.2025.101450_bib55","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1651-2227.1992.tb12300.x","article-title":"Normal Y sequences in Smith-Lemli-Opitz syndrome with total failure of masculinization","volume":"81","author":"Fukazawa","year":"1992","journal-title":"Acta Paediatr"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib56","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0022-3476(95)70261-X","article-title":"Correlation of severity and outcome with plasma sterol levels in variants of the Smith-Lemli-Opitz syndrome","volume":"127","author":"Tint","year":"1995","journal-title":"J Pediatr"},{"issue":"7","key":"10.1016\/j.gim.2025.101450_bib57","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/jmg.35.7.558","article-title":"Smith-Lemli-Opitz syndrome: a variable clinical and biochemical phenotype","volume":"35","author":"Ryan","year":"1998","journal-title":"J Med Genet"},{"issue":"9","key":"10.1016\/j.gim.2025.101450_bib58","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/hmg\/9.9.1385","article-title":"Spectrum of Delta(7)-dehydrocholesterol reductase mutations in patients with the Smith-Lemli-Opitz (RSH) syndrome","volume":"9","author":"Yu","year":"2000","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib59","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0022-2275(20)32412-3","article-title":"Cholesterol deficit but not accumulation of aberrant sterols is the major cause of the teratogenic activity in the Smith-Lemli-Opitz syndrome animal model","volume":"41","author":"Gaoua","year":"2000","journal-title":"J Lipid Res"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib60","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1194\/jlr.M031732","article-title":"Assays of plasma dehydrocholesteryl esters and oxysterols from Smith-Lemli-Opitz syndrome patients","volume":"54","author":"Liu","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.gim.2025.101450_bib61","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s11689-016-9145-x","article-title":"Development, behavior, and biomarker characterization of Smith-Lemli-Opitz syndrome: an update","volume":"8","author":"Thurm","year":"2016","journal-title":"J Neurodev Disord"},{"issue":"suppl 14","key":"10.1016\/j.gim.2025.101450_bib62","first-page":"S91","article-title":"The Anatomic Severity Scale Correlates with Level of Impairment on Measurements of Autism and Intellectual Disability in Children with Smith-Lemli-Opitz Syndrome (SLOS)","volume":"68","author":"Lee","year":"2010","journal-title":"Ann Neurol"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib63","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/tpj.2016.48","article-title":"Investigation of 7-dehydrocholesterol reductase pathway to elucidate off-target prenatal effects of pharmaceuticals: a systematic review","volume":"16","author":"Boland","year":"2016","journal-title":"Pharmacogenomics J"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib64","article-title":"Statins for Smith-Lemli-Opitz syndrome","volume":"2020","author":"Ballout","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib65","doi-asserted-by":"crossref","first-page":"287","DOI":"10.5603\/GP.2020.0049","article-title":"GC-MS as a tool for reliable non-invasive prenatal diagnosis of Smith-Lemli-Opitz syndrome but essential also for other cholesterolopathies verification","volume":"91","author":"Jezela-Stanek","year":"2020","journal-title":"Ginekol Pol"},{"issue":"17","key":"10.1016\/j.gim.2025.101450_bib66","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1007\/s00216-015-8731-1","article-title":"LC-MS\/MS-based quantification of cholesterol and related metabolites in dried blood for the screening of inborn errors of sterol metabolism","volume":"407","author":"Becker","year":"2015","journal-title":"Anal Bioanal Chem"},{"issue":"9","key":"10.1016\/j.gim.2025.101450_bib67","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1194\/jlr.D800017-JLR200","article-title":"Highly sensitive analysis of sterol profiles in human serum by LC-ESI-MS\/MS","volume":"49","author":"Honda","year":"2008","journal-title":"J Lipid Res"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib68","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/(SICI)1096-8628(19990219)82:5<376::AID-AJMG4>3.0.CO;2-B","article-title":"Prenatal diagnosis of the RSH\/Smith-Lemli-Opitz syndrome","volume":"82","author":"Kratz","year":"1999","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib69","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1097-0223(200003)20:3<238::AID-PD792>3.0.CO;2-W","article-title":"Fetal demise with Smith-Lemli-Opitz syndrome confirmed by tissue sterol analysis and the absence of measurable 7-dehydrocholesterol Delta(7)-reductase activity in chorionic villi","volume":"20","author":"Linck","year":"2000","journal-title":"Prenat Diagn"},{"issue":"10","key":"10.1016\/j.gim.2025.101450_bib70","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41436-021-01203-z","article-title":"Screening for autosomal recessive and X-linked conditions during pregnancy and preconception: a practice resource of the American College of Medical Genetics and Genomics (ACMG)","volume":"23","author":"Gregg","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.gim.2025.101450_bib71","series-title":"Genetic Syndromes: A Comprehensive Reference Guide","first-page":"1","article-title":"Smith-Lemli-Opitz syndrome (SLOS)","author":"Ballout","year":"2020"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib72","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/(SICI)1096-8628(19990212)82:4<355::AID-AJMG16>3.0.CO;2-4","article-title":"Levels of unconjugated estriol and other maternal serum markers in pregnancies with Smith-Lemli-Opitz (RSH) syndrome fetuses","volume":"82","author":"Bradley","year":"1999","journal-title":"Am J Med Genet"},{"issue":"9","key":"10.1016\/j.gim.2025.101450_bib73","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pd.1518","article-title":"Identifying Smith-Lemli-Opitz syndrome in conjunction with prenatal screening for Down syndrome","volume":"26","author":"Craig","year":"2006","journal-title":"Prenat Diagn"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib74","first-page":"167","article-title":"Maternal serum unconjugated estriol as a predictor for Smith-Lemli-Opitz syndrome and other fetal conditions","volume":"102","author":"Schoen","year":"2003","journal-title":"Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib75","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/ajmg.1320560309","article-title":"Prenatal detection of the cholesterol biosynthetic defect in the Smith-Lemli-Opitz syndrome by the analysis of amniotic fluid sterols","volume":"56","author":"Abuelo","year":"1995","journal-title":"Am J Med Genet"},{"issue":"8","key":"10.1016\/j.gim.2025.101450_bib76","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1373\/clinchem.2007.100644","article-title":"Potential of sterol analysis by liquid chromatography-tandem mass spectrometry for the prenatal diagnosis of Smith-Lemli-Opitz syndrome","volume":"54","author":"Griffiths","year":"2008","journal-title":"Clin Chem"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib77","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0009-8981(95)06038-4","article-title":"Diagnosis of Smith-Lemli-Opitz syndrome by gas chromatography\/mass spectrometry of 7-dehydrocholesterol in plasma, amniotic fluid and cultured skin fibroblasts","volume":"236","author":"Kelley","year":"1995","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.gim.2025.101450_bib78","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/(SICI)1097-0223(199807)18:7<651::AID-PD316>3.0.CO;2-V","article-title":"Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterols","volume":"18","author":"Tint","year":"1998","journal-title":"Prenat Diagn"},{"issue":"7","key":"10.1016\/j.gim.2025.101450_bib79","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/pd.1735","article-title":"Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis","volume":"27","author":"Waye","year":"2007","journal-title":"Prenat Diagn"},{"issue":"18","key":"10.1016\/j.gim.2025.101450_bib80","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/ajmg.a.31901","article-title":"Dehydrosteroid measurements in maternal urine or serum for the prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS)","volume":"143A","author":"Shackleton","year":"2007","journal-title":"Am J Med Genet A"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41380-019-0368-6","article-title":"Maternal aripiprazole exposure interacts with 7-dehydrocholesterol reductase mutations and alters embryonic neurodevelopment","volume":"24","author":"Genaro-Mattos","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"11","key":"10.1016\/j.gim.2025.101450_bib82","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1038\/s41380-020-0801-x","article-title":"Maternal cariprazine exposure inhibits embryonic and postnatal brain cholesterol biosynthesis","volume":"25","author":"Genaro-Mattos","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib83","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/acschemneuro.0c00765","article-title":"Prescription medications alter neuronal and glial cholesterol synthesis","volume":"12","author":"Tallman","year":"2021","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib84","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pedhc.2018.08.014","article-title":"Novel withdrawal symptoms of a neonate prenatally exposed to a fentanyl analog","volume":"33","author":"Nellhaus","year":"2019","journal-title":"J Pediatr Health Care"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib85","article-title":"A novel syndrome associated with prenatal fentanyl exposure","volume":"1","author":"Wadman","year":"2023","journal-title":"Genet Med Open"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib86","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1194\/jlr.P048603","article-title":"On the formation of 7-ketocholesterol from 7-dehydrocholesterol in patients with CTX and SLO","volume":"55","author":"Bj\u00f6rkhem","year":"2014","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib87","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0022-2275(20)42047-4","article-title":"Use of determinations of 7-lathosterol (5 alpha-cholest-7-en-3 beta-ol) and other cholesterol precursors in serum in the study and treatment of disturbances of sterol metabolism, particularly cerebrotendinous xanthomatosis","volume":"32","author":"Wolthers","year":"1991","journal-title":"J Lipid Res"},{"issue":"1-2","key":"10.1016\/j.gim.2025.101450_bib88","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ymgme.2004.07.002","article-title":"Lowered DHCR7 activity measured by ergosterol conversion in multiple cell types in Smith-Lemli-Opitz syndrome","volume":"83","author":"Ginat","year":"2004","journal-title":"Mol Genet Metab"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib89","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/sj.ejhg.5200579","article-title":"Frequency gradients of DHCR7 mutations in patients with Smith-Lemli-Opitz syndrome in Europe: evidence for different origins of common mutations","volume":"9","author":"Witsch-Baumgartner","year":"2001","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib90","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/humu.2","article-title":"Mutations in the human DHCR7 gene","volume":"17","author":"Witsch-Baumgartner","year":"2001","journal-title":"Hum Mutat"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib91","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ajmg.c.31346","article-title":"Mutational spectrum of Smith-Lemli-Opitz syndrome","volume":"160C","author":"Waterham","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib92","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jmg.2004.022749","article-title":"DHCR7 nonsense mutations and characterisation of mRNA nonsense mediated decay in Smith-Lemli-Opitz syndrome","volume":"42","author":"Correa-Cerro","year":"2005","journal-title":"J Med Genet"},{"issue":"8","key":"10.1016\/j.gim.2025.101450_bib93","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1136\/jmg.2004.018085","article-title":"Maternal apo E genotype is a modifier of the Smith-Lemli-Opitz syndrome","volume":"41","author":"Witsch-Baumgartner","year":"2004","journal-title":"J Med Genet"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib94","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/ejhg.2012.169","article-title":"Maternal ABCA1 genotype is associated with severity of Smith-Lemli-Opitz syndrome and with viability of patients homozygous for null mutations","volume":"21","author":"Lanthaler","year":"2013","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib95","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1203\/PDR.0b013e31819ea4eb","article-title":"Effects of dietary cholesterol and simvastatin on cholesterol synthesis in Smith-Lemli-Opitz syndrome","volume":"65","author":"Chan","year":"2009","journal-title":"Pediatr Res"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib96","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<305::AID-AJMG11>3.0.CO;2-X","article-title":"Clinical effects of cholesterol supplementation in six patients with the Smith-Lemli-Opitz syndrome (SLOS)","volume":"68","author":"Elias","year":"1997","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib97","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s10545-007-0537-7","article-title":"Effects of cholesterol and simvastatin treatment in patients with Smith-Lemli-Opitz syndrome (SLOS)","volume":"30","author":"Haas","year":"2007","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib98","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<311::AID-AJMG12>3.0.CO;2-W","article-title":"Treatment of Smith-Lemli-Opitz syndrome: results of a multicenter trial","volume":"68","author":"Irons","year":"1997","journal-title":"Am J Med Genet"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib99","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<315::AID-AJMG13>3.0.CO;2-W","article-title":"Cholesterol and bile acid replacement therapy in children and adults with Smith-Lemli-Opitz (SLO\/RSH) syndrome","volume":"68","author":"Nwokoro","year":"1997","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib100","first-page":"783","article-title":"Cholesterol supplementation does not improve developmental progress in Smith-Lemli-Opitz syndrome","volume":"144","author":"Sikora","year":"2004","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib101","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/1096-8628(20000828)93:5<360::AID-AJMG4>3.0.CO;2-P","article-title":"Cholesterol supplementation with egg yolk increases plasma cholesterol and decreases plasma 7-dehydrocholesterol in Smith-Lemli-Opitz syndrome","volume":"93","author":"Linck","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.gim.2025.101450_bib102","series-title":"Cassidy and Allanson\u2019s Management of Genetic Syndromes","first-page":"851","article-title":"Smith-Lemli-Opitz syndrome","author":"Latham","year":"2021"},{"issue":"9","key":"10.1016\/j.gim.2025.101450_bib103","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/S0022-2275(20)33456-8","article-title":"Sterol balance in the Smith-Lemli-Opitz syndrome. Reduction in whole body cholesterol synthesis and normal bile acid production","volume":"41","author":"Steiner","year":"2000","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/09540260801889062","article-title":"Autism: the role of cholesterol in treatment","volume":"20","author":"Aneja","year":"2008","journal-title":"Int Rev Psychiatry"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib105","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2133.2001.03964.x","article-title":"Cholesterol supplementation objectively reduces photosensitivity in the Smith-Lemli-Opitz syndrome","volume":"144","author":"Azurdia","year":"2001","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib106","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/s41398-021-01580-8","article-title":"Sterol and lipid analyses identifies hypolipidemia and apolipoprotein disorders in autism associated with adaptive functioning deficits","volume":"11","author":"Tierney","year":"2021","journal-title":"Transl Psychiatry"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib107","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ajmg.a.33148","article-title":"Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome","volume":"152A","author":"Tierney","year":"2010","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.gim.2025.101450_bib108","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2020.105794","article-title":"Bile acid biosynthesis in Smith-Lemli-Opitz syndrome bypassing cholesterol: potential importance of pathway intermediates","volume":"206","author":"Abdel-Khalik","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib109","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1194\/jlr.D083246","article-title":"Identification of unusual oxysterols and bile acids with 7-oxo or 3\u03b2,5\u03b1,6\u03b2-trihydroxy functions in human plasma by charge-tagging mass spectrometry with multistage fragmentation","volume":"59","author":"Griffiths","year":"2018","journal-title":"J Lipid Res"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib110","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/ajmg.1320500413","article-title":"Abnormal bile acids in the Smith-Lemli-Opitz syndrome","volume":"50","author":"Natowicz","year":"1994","journal-title":"Am J Med Genet"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib111","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1203\/01.PDR.0000157723.98422.B5","article-title":"Intestinal absorption of cholesterol by patients with Smith-Lemli-Opitz syndrome","volume":"57","author":"Lin","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.gim.2025.101450_bib112","article-title":"Cholic acid increases plasma cholesterol in Smith-Lemli-Opitz syndrome: A pilot study","volume":"38","author":"Elias","year":"2024","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib113","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-973760","article-title":"Smith-Lemli-Opitz syndrome: treatment with cholesterol and bile acids","volume":"27","author":"Ullrich","year":"1996","journal-title":"Neuropediatrics"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib114","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1096-8628(19970131)68:3<282::AID-AJMG7>3.0.CO;2-O","article-title":"Sterol concentrations in cultured Smith-Lemli-Opitz syndrome skin fibroblasts: diagnosis of a biochemically atypical case of the syndrome","volume":"68","author":"Honda","year":"1997","journal-title":"Am J Med Genet"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib115","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ajmg.c.31347","article-title":"Treatment of Smith-Lemli-Opitz syndrome and other sterol disorders","volume":"160C","author":"Svoboda","year":"2012","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"5","key":"10.1016\/j.gim.2025.101450_bib116","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.bbalip.2017.01.007","article-title":"The interrelationship between bile acid and vitamin A homeostasis","volume":"1862","author":"Saeed","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"19","key":"10.1016\/j.gim.2025.101450_bib117","doi-asserted-by":"crossref","first-page":"14486","DOI":"10.1074\/jbc.M110.116004","article-title":"Regulation of bile acid synthesis by fat-soluble vitamins A and D","volume":"285","author":"Schmidt","year":"2010","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib118","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1053\/j.gastro.2003.11.058","article-title":"Cholic acid supplementation enhances cholesterol absorption in humans","volume":"126","author":"Woollett","year":"2004","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib119","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2796.2002.01037.x","article-title":"Cholesterol treatment forever? The first Scandinavian trial of cholesterol supplementation in the cholesterol-synthesis defect Smith-Lemli-Opitz syndrome","volume":"252","author":"Starck","year":"2002","journal-title":"J Intern Med"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib120","first-page":"710","article-title":"Abnormal cholesterol metabolism in Smith-Lemli-Opitz syndrome","volume":"7","author":"Elias","year":"1995","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib121","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2013.06.013","article-title":"Antioxidant supplementation ameliorates molecular deficits in Smith-Lemli-Opitz syndrome","volume":"75","author":"Korade","year":"2014","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib122","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.nbd.2011.12.011","article-title":"DHCEO accumulation is a critical mediator of pathophysiology in a Smith-Lemli-Opitz syndrome model","volume":"45","author":"Xu","year":"2012","journal-title":"Neurobiol Dis"},{"issue":"8","key":"10.1016\/j.gim.2025.101450_bib123","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.3390\/biom11081228","article-title":"Biochemical and clinical effects of vitamin E supplementation in Hungarian Smith-Lemli-Opitz syndrome patients","volume":"11","author":"Koczok","year":"2021","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib124","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4172\/2161-1041.1000119","article-title":"Antioxidants: the missing key to improved therapeutic intervention in Smith-Lemli-Opitz syndrome?","volume":"2","author":"Fliesler","year":"2013","journal-title":"Hereditary Genet"},{"key":"10.1016\/j.gim.2025.101450_bib126","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.exer.2016.01.016","article-title":"Differential cytotoxic effects of 7-dehydrocholesterol-derived oxysterols on cultured retina-derived cells: dependence on sterol structure, cell type, and density","volume":"145","author":"Pfeffer","year":"2016","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.gim.2025.101450_bib127","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/S0022-2275(20)33442-8","article-title":"Simvastatin. A new therapeutic approach for Smith-Lemli-Opitz syndrome","volume":"41","author":"Jira","year":"2000","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib128","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/hmg\/ddl003","article-title":"Development and characterization of a hypomorphic Smith-Lemli-Opitz syndrome mouse model and efficacy of simvastatin therapy","volume":"15","author":"Correa-Cerro","year":"2006","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gim.2025.101450_bib129","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1120373","article-title":"Smith-Lemli-Opitz syndrome: a pathophysiological manifestation of the Bloch hypothesis","volume":"10","author":"Chattopadhyay","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ymgme.2004.12.009","article-title":"Residual cholesterol synthesis and simvastatin induction of cholesterol synthesis in Smith-Lemli-Opitz syndrome fibroblasts","volume":"85","author":"Wassif","year":"2005","journal-title":"Mol Genet Metab"},{"issue":"3","key":"10.1016\/j.gim.2025.101450_bib131","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/gim.2016.102","article-title":"A placebo-controlled trial of simvastatin therapy in Smith-Lemli-Opitz syndrome","volume":"19","author":"Wassif","year":"2017","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.gim.2025.101450_bib132","article-title":"Statins for Smith-Lemli-Opitz syndrome","volume":"11","author":"Ballout","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib133","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajmg.10722","article-title":"Simvastatin treatment in the SLO syndrome: a safe approach?","volume":"113","author":"Starck","year":"2002","journal-title":"Am J Med Genet"},{"issue":"1","key":"10.1016\/j.gim.2025.101450_bib134","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2478\/bjmg-2021-0002","article-title":"Smith-Lemli-Opitz syndrome: Bosnian and Herzegovinian experience","volume":"24","author":"Begic","year":"2021","journal-title":"Balkan J Med Genet"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib135","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/BF03018947","article-title":"Anesthetic considerations in Smith-Lemli-Opitz syndrome","volume":"47","author":"Choi","year":"2000","journal-title":"Can J Anaesth"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib136","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/00000542-200210000-00041","article-title":"Anesthesia and airway management of pediatric patients with Smith-Lemli-Opitz syndrome","volume":"97","author":"Quezado","year":"2002","journal-title":"Anesthesiology"},{"issue":"4","key":"10.1016\/j.gim.2025.101450_bib137","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1017\/S0954579407000612","article-title":"Mendelian randomization: a novel test of the gateway hypothesis and models of gene-environment interplay","volume":"19","author":"Irons","year":"2007","journal-title":"Dev Psychopathol"},{"issue":"1-2","key":"10.1016\/j.gim.2025.101450_bib138","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.ymgme.2013.04.004","article-title":"Aripiprazole and trazodone cause elevations of 7-dehydrocholesterol in the absence of Smith-Lemli-Opitz syndrome","volume":"110","author":"Hall","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.gim.2025.101450_bib139","article-title":"Generation and validation of a conditional knockout mouse model for the study of the Smith-Lemli-Opitz syndrome","volume":"62","author":"Kanuri","year":"2021","journal-title":"J Lipid Res"},{"issue":"2","key":"10.1016\/j.gim.2025.101450_bib140","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/00006534-200208000-00004","article-title":"Health-related quality of life in children with craniofacial anomalies","volume":"110","author":"Warschausky","year":"2002","journal-title":"Plast Reconstr Surg"},{"issue":"6","key":"10.1016\/j.gim.2025.101450_bib141","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1080\/016128402760210190","article-title":"The challenge of providing continuity in the care of a disabled child: Smith-Lemli-Opitz syndrome","volume":"23","author":"Koenig","year":"2002","journal-title":"Issues Ment Health Nurs"},{"issue":"suppl 2","key":"10.1016\/j.gim.2025.101450_bib142","first-page":"27","article-title":"DSD interpreter, a mobile application-based tool for point of care evaluation of atypical genitalia","volume":"96","author":"Raithatha","year":"2023","journal-title":"Horm Res Paediatr"}],"container-title":["Genetics in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025000978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098360025000978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T07:13:56Z","timestamp":1786691636000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098360025000978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":137,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S1098360025000978"],"URL":"https:\/\/doi.org\/10.1016\/j.gim.2025.101450","relation":{},"ISSN":["1098-3600"],"issn-type":[{"value":"1098-3600","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smith-Lemli-Opitz syndrome: Clinical, biochemical, and genetic insights with emerging treatment opportunities","name":"articletitle","label":"Article Title"},{"value":"Genetics in Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gim.2025.101450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of American College of Medical Genetics and Genomics.","name":"copyright","label":"Copyright"}],"article-number":"101450"}}